These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6839560

  • 1. Accumulation and excretion of middle molecules.
    Asaba H.
    Clin Nephrol; 1983 Mar; 19(3):116-23. PubMed ID: 6839560
    [Abstract] [Full Text] [Related]

  • 2. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
    Lustenberger N, Schindhelm K, Nordmeyer C, Schurek HJ, Stolte H.
    Artif Organs; 1981 Mar; 4 Suppl():110-4. PubMed ID: 7295076
    [Abstract] [Full Text] [Related]

  • 3. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J.
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [Abstract] [Full Text] [Related]

  • 4. Uremic middle molecules in non-dialyzed azotemic patients: relation to symptoms and clinical biochemistries.
    Asaba H, Alvestrand A, Bergström J, Fürst P, Yahiel V.
    Clin Nephrol; 1982 Feb; 17(2):90-5. PubMed ID: 7067171
    [Abstract] [Full Text] [Related]

  • 5. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H, Bergström J, Fürst P, Johnson C, Yahiel V.
    Artif Organs; 1981 Feb; 4 Suppl():137-42. PubMed ID: 7295080
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical implications of uremic middle molecules in regular hemodialysis patients.
    Asaba H, Alvestrand A, Fürst P, Bergström J.
    Clin Nephrol; 1983 Apr; 19(4):179-87. PubMed ID: 6851254
    [Abstract] [Full Text] [Related]

  • 8. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F, Arrobas M, Luna E, Naranjo M, Pizarro JL, Sánchez-Casado E.
    Nefrologia; 2002 Apr; 22(5):432-7. PubMed ID: 12497744
    [Abstract] [Full Text] [Related]

  • 9. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P, Zimmerman L, Bergström J.
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modeling of middle molecules in clinical studies.
    Gotch FA, Sargent JA.
    Artif Organs; 1981 Apr; 4 Suppl():133-6. PubMed ID: 7295079
    [Abstract] [Full Text] [Related]

  • 13. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G, Chu J, Liu X, Yuan Z.
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [Abstract] [Full Text] [Related]

  • 14. Effect of chronic dietary protein intake on the renal function in healthy subjects.
    Brändle E, Sieberth HG, Hautmann RE.
    Eur J Clin Nutr; 1996 Nov; 50(11):734-40. PubMed ID: 8933120
    [Abstract] [Full Text] [Related]

  • 15. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L, Dall'taglio P, Buzio C.
    Clin Nephrol; 1975 Nov; 3(3):82-93. PubMed ID: 1139803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence that urea is a better surrogate marker of uremic toxicity than creatinine.
    Mehrotra R, Saran R, Nolph KD, Moore HL, Khanna R.
    ASAIO J; 1997 Nov; 43(5):M858-61. PubMed ID: 9360168
    [Abstract] [Full Text] [Related]

  • 18. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
    Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y.
    Am J Kidney Dis; 2005 Sep; 46(3):512-9. PubMed ID: 16129214
    [Abstract] [Full Text] [Related]

  • 19. Investigation of the clearance and generation rate of endogenous peptides in normal subjects and uremic patients.
    Peters JH, Gotch FA, Keen M, Berridge BJ, Chao WR.
    Trans Am Soc Artif Intern Organs; 1974 Sep; 20 B():417-23. PubMed ID: 4450293
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical and clinical evidence for uremic toxicity.
    Bouré T, Vanholder R.
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.